Evaluation of TNF-alpha Antagonists (Infliximab) Withdrawal in Sarcoidosis
Evaluation of TNF-alpha Antagonists (Infliximab) Withdrawal in Sarcoidosis
Active, not recruiting · NCT05689879 · Registry updated 2026-04-24Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Evaluation of TNF-alpha Antagonists (Infliximab) Withdrawal in Sarcoidosis | Hemic and Lymphatic Diseases, Hypersensitivity, Delayed, immune system disorder, lymphatic system disorder, lymphoproliferative syndrome, sarcoidosis | Active, not recruiting | Phase 3 | 2026-04-24 | NCT05689879 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Assistance Publique - Hôpitaux de Paris | 985 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Hôpital de la Pitié-Salpêtrière | Paris | France | 6 |